Latest posts
-
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
NEW YORK, NY, October 24, 2023 – The biotech sector, known for its exponential growth potential, is currently facing highly challenging market conditions. Influences like rising inflation, geopolitical tensions, and looming economic recessions have led to a sharp decline in the sector. Consequently, many small and micro-cap biotech companies are trading at all-time lows, with
-
TransGlobal Assets Inc. (OTC: TMSH) Wholly Owned Subsidiary, Better Health Sciences Inc., Signs an Exclusive Joint-Venture with Canna-King
Ann Arbor, Michigan, October 24, 2023 – TransGlobal Assets Inc. (OTC: TMSH) a holdings company whose subsidiaries specialize in offering advanced products and services and assist patients in obtaining their medical licenses to produce and/or obtain medical cannabis from licensed producers is pleased to announce an Exclusive Joint-Venture with Canna-King. The Exclusive Joint-Venture will encompass
-
BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
Study to support differentiated efficacy of Vendaje® structural tissue allograft POMPANO BEACH, FLORIDA, October 24, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today announced that the first site is now fully opened for its clinical
-
Argentum 47, Inc. Moves into Online Cloud Business with New SaaS Module
WINDSOR, BERKSHIRE, UK, October 24, 2023 – Argentum 47, Inc. (OTC PINK: ARGQ), a leading provider of AI-powered digital marketing solutions including branding, advertising, and lead generation, today announced that it has developed the Company’s proprietary AI Technology and platforms into a SaaS (Software-as-a-Service) model. Argentum 47 unifies all aspects of Marketing under one roof
-
Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference
Pittsburgh, PA, October 23, 2023 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our, “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, will present at the 2023 virtual Fall Foliage MicroCap Rodeo Conference to be held from October 24th – 27th. Dr. Jonathan Kaufman, CEO of Lipella, said: “2023
-
PRISM MediaWire – Weekly Press Resume – Oct. 16 to Oct. 20, 2023
New York, New York, October 20, 2023 PRISM MediaWire – Weekly Press Resume Oct. 16 to Oct. 20, 2023 BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference POMPANO BEACH, FLORIDA, October 17, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture,
-
Argentum 47 Inc. Ventures into the European Medical Cannabis Industry to Capitalize on the Growing Market
WINDSOR, BERKSHIRE, United Kingdom, October 19, 2023 – Argentum 47, Inc. (“Argentum” or the “Company”)(www.argq.io) (OTC PINK: ARGQ), a leading provider of AI-powered digital marketing solutions including branding, advertising, and lead generation, announced today that it has entered into talks with a European medical cannabis company that is fully integrated with strategic assets along the
-
SinglePoint Inc. Acquires remaining 49% of Box Pure Air LLC, Implements Strategic Restructuring to Enhance Indoor Air Revenue Opportunity with Schools in California, Box Pure Air LLC Now a Wholly Owned Subsidiary
$800,000 in pending orders to fulfill through the $5,000,000 Grant Award Notification (GAN) in California SinglePoint Inc. retains minority interest in Ballistic Product America, LLC (“Ballistic”) Ballistic has entered into an agreement with SinglePoint in which it Ballistic agrees to pay to SinglePoint, as a periodic royalty (“Royalty”), five percent of the gross revenue of
-
BioStem Technologies to Present at the Fall Foliage MicroCap Rodeo Conference
POMPANO BEACH, FLORIDA, October 18, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, will present at the 2023 virtual Fall Foliage MicroCap Rodeo Conference to be held from October 24th – 27th. Jason Matuszewski, Chief Executive